Lauren Vanderlinden
Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 12 | 2026 | 725 | 2.190 |
Why?
| | Islets of Langerhans | 10 | 2026 | 852 | 1.570 |
Why?
| | Autoimmunity | 13 | 2026 | 925 | 1.560 |
Why?
| | Diabetes Mellitus, Type 1 | 16 | 2026 | 3930 | 1.080 |
Why?
| | Alcohol Drinking | 6 | 2018 | 850 | 0.910 |
Why?
| | Arthritis, Rheumatoid | 4 | 2026 | 1185 | 0.630 |
Why?
| | Rats, Inbred Strains | 4 | 2019 | 316 | 0.610 |
Why?
| | Quantitative Trait Loci | 5 | 2020 | 388 | 0.600 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2022 | 241 | 0.590 |
Why?
| | Smoking | 1 | 2025 | 1486 | 0.540 |
Why?
| | Quantitative Trait, Heritable | 2 | 2017 | 119 | 0.520 |
Why?
| | Autoantibodies | 7 | 2026 | 1500 | 0.510 |
Why?
| | Genetic Predisposition to Disease | 9 | 2026 | 2488 | 0.510 |
Why?
| | Genome-Wide Association Study | 7 | 2026 | 1537 | 0.490 |
Why?
| | Gene Regulatory Networks | 4 | 2019 | 319 | 0.470 |
Why?
| | Brain | 8 | 2022 | 2991 | 0.450 |
Why?
| | Seroconversion | 3 | 2026 | 48 | 0.430 |
Why?
| | Darkness | 1 | 2015 | 26 | 0.430 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 2 | 2025 | 88 | 0.430 |
Why?
| | Alcoholism | 3 | 2014 | 830 | 0.370 |
Why?
| | Oxylipins | 3 | 2023 | 47 | 0.360 |
Why?
| | Phenotype | 3 | 2026 | 3206 | 0.330 |
Why?
| | Vitamin D | 2 | 2026 | 402 | 0.320 |
Why?
| | Epigenesis, Genetic | 6 | 2026 | 712 | 0.310 |
Why?
| | Circadian Rhythm | 1 | 2015 | 515 | 0.310 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2025 | 2240 | 0.290 |
Why?
| | Male | 34 | 2026 | 73396 | 0.280 |
Why?
| | Body Mass Index | 4 | 2025 | 2458 | 0.280 |
Why?
| | Child | 19 | 2026 | 22693 | 0.270 |
Why?
| | Systems Biology | 2 | 2019 | 68 | 0.270 |
Why?
| | Algorithms | 3 | 2024 | 1849 | 0.260 |
Why?
| | Protein Interaction Maps | 2 | 2026 | 54 | 0.250 |
Why?
| | CpG Islands | 3 | 2023 | 175 | 0.250 |
Why?
| | Longitudinal Studies | 5 | 2026 | 3017 | 0.240 |
Why?
| | Case-Control Studies | 9 | 2026 | 3647 | 0.240 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2021 | 259 | 0.230 |
Why?
| | Humans | 43 | 2026 | 146342 | 0.220 |
Why?
| | Genotype | 4 | 2025 | 1879 | 0.220 |
Why?
| | Adolescent | 14 | 2026 | 22557 | 0.220 |
Why?
| | Female | 30 | 2026 | 79499 | 0.220 |
Why?
| | Diet | 3 | 2021 | 1273 | 0.210 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2026 | 129 | 0.210 |
Why?
| | Child, Preschool | 13 | 2026 | 11913 | 0.210 |
Why?
| | Metabolomics | 5 | 2021 | 738 | 0.200 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2021 | 49 | 0.200 |
Why?
| | Disease Progression | 4 | 2026 | 2867 | 0.200 |
Why?
| | Gene Expression Profiling | 4 | 2021 | 1792 | 0.200 |
Why?
| | Mice, Inbred Strains | 2 | 2015 | 384 | 0.200 |
Why?
| | Ethanol | 2 | 2018 | 630 | 0.190 |
Why?
| | Extracellular Matrix | 2 | 2021 | 565 | 0.190 |
Why?
| | Rats | 9 | 2019 | 5586 | 0.190 |
Why?
| | Adiposity | 2 | 2017 | 533 | 0.190 |
Why?
| | Animals | 19 | 2022 | 38107 | 0.180 |
Why?
| | Biomarkers, Tumor | 2 | 2021 | 1339 | 0.180 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 70 | 0.170 |
Why?
| | Pregnancy | 6 | 2025 | 7230 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 370 | 0.170 |
Why?
| | Heart Murmurs | 1 | 2021 | 13 | 0.170 |
Why?
| | Diabetes, Gestational | 1 | 2025 | 307 | 0.170 |
Why?
| | Lipid Metabolism | 3 | 2019 | 533 | 0.160 |
Why?
| | Risk Factors | 7 | 2023 | 10921 | 0.160 |
Why?
| | Propensity Score | 1 | 2023 | 376 | 0.160 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 133 | 0.160 |
Why?
| | Vitamins | 1 | 2022 | 183 | 0.160 |
Why?
| | Diseases in Twins | 1 | 2021 | 115 | 0.160 |
Why?
| | Hyaluronan Receptors | 1 | 2021 | 105 | 0.160 |
Why?
| | B-Lymphocytes | 1 | 2026 | 887 | 0.160 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2025 | 665 | 0.160 |
Why?
| | Neutrophils | 1 | 2026 | 1133 | 0.160 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2020 | 15 | 0.150 |
Why?
| | Receptors, Androgen | 1 | 2021 | 149 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 159 | 0.150 |
Why?
| | Phospholipids | 1 | 2021 | 215 | 0.150 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 752 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 219 | 0.150 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.150 |
Why?
| | Drosophila | 1 | 2020 | 168 | 0.140 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 102 | 0.140 |
Why?
| | Fluorenes | 1 | 2019 | 46 | 0.140 |
Why?
| | Eicosanoids | 1 | 2019 | 58 | 0.140 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 283 | 0.140 |
Why?
| | Drosophila Proteins | 1 | 2020 | 207 | 0.140 |
Why?
| | Mice | 9 | 2022 | 18297 | 0.140 |
Why?
| | Scoliosis | 1 | 2021 | 231 | 0.140 |
Why?
| | Metabolic Clearance Rate | 1 | 2018 | 115 | 0.140 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 23 | 0.140 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 121 | 0.130 |
Why?
| | Food Hypersensitivity | 1 | 2020 | 165 | 0.130 |
Why?
| | Phthalic Acids | 1 | 2018 | 43 | 0.130 |
Why?
| | Endocrine Disruptors | 1 | 2018 | 42 | 0.130 |
Why?
| | Hippocampus | 2 | 2022 | 989 | 0.130 |
Why?
| | Cohort Studies | 3 | 2026 | 6077 | 0.130 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2017 | 3 | 0.130 |
Why?
| | Insulin | 4 | 2025 | 2525 | 0.130 |
Why?
| | GABA Modulators | 1 | 2017 | 11 | 0.130 |
Why?
| | CD24 Antigen | 1 | 2017 | 18 | 0.130 |
Why?
| | Health Status | 1 | 2023 | 827 | 0.130 |
Why?
| | Genetic Association Studies | 2 | 2020 | 379 | 0.130 |
Why?
| | Fatty Acids | 2 | 2017 | 460 | 0.130 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 319 | 0.120 |
Why?
| | Prospective Studies | 4 | 2023 | 8123 | 0.120 |
Why?
| | Insulin Resistance | 1 | 2025 | 1247 | 0.120 |
Why?
| | Transcriptome | 3 | 2018 | 1068 | 0.120 |
Why?
| | Voltage-Gated Sodium Channels | 1 | 2016 | 5 | 0.120 |
Why?
| | Multifactorial Inheritance | 1 | 2018 | 243 | 0.120 |
Why?
| | Cross-Sectional Studies | 3 | 2023 | 5899 | 0.120 |
Why?
| | Maternal Exposure | 1 | 2018 | 189 | 0.120 |
Why?
| | Receptors, GABA-A | 1 | 2017 | 138 | 0.120 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 193 | 0.120 |
Why?
| | Seizures | 1 | 2020 | 489 | 0.110 |
Why?
| | Phenylurea Compounds | 1 | 2016 | 122 | 0.110 |
Why?
| | Anxiety | 1 | 2022 | 1125 | 0.110 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2015 | 18 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2021 | 1432 | 0.110 |
Why?
| | Quinolines | 1 | 2016 | 191 | 0.110 |
Why?
| | Microarray Analysis | 1 | 2015 | 117 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 539 | 0.110 |
Why?
| | Birth Weight | 1 | 2017 | 521 | 0.100 |
Why?
| | Neuralgia | 1 | 2016 | 141 | 0.100 |
Why?
| | Principal Component Analysis | 1 | 2015 | 192 | 0.100 |
Why?
| | Prognosis | 4 | 2026 | 4351 | 0.100 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 233 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2623 | 0.100 |
Why?
| | Cell Nucleus | 1 | 2017 | 584 | 0.100 |
Why?
| | Obesity | 2 | 2017 | 3131 | 0.100 |
Why?
| | Follow-Up Studies | 4 | 2026 | 5439 | 0.100 |
Why?
| | Cell Proliferation | 2 | 2021 | 2502 | 0.100 |
Why?
| | Infant | 7 | 2024 | 10114 | 0.100 |
Why?
| | Genetic Variation | 1 | 2019 | 996 | 0.100 |
Why?
| | Behavior, Addictive | 1 | 2014 | 90 | 0.100 |
Why?
| | Species Specificity | 1 | 2014 | 543 | 0.090 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 447 | 0.090 |
Why?
| | Adenylyl Cyclases | 1 | 2012 | 60 | 0.090 |
Why?
| | Gene Expression | 1 | 2017 | 1463 | 0.090 |
Why?
| | Choice Behavior | 1 | 2014 | 179 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 902 | 0.090 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2012 | 82 | 0.090 |
Why?
| | Ibuprofen | 1 | 2012 | 87 | 0.090 |
Why?
| | Pediatrics | 1 | 2020 | 1124 | 0.090 |
Why?
| | Neurons | 2 | 2020 | 1668 | 0.090 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 124 | 0.090 |
Why?
| | Lipocalin 1 | 1 | 2011 | 2 | 0.080 |
Why?
| | Base Sequence | 1 | 2015 | 2123 | 0.080 |
Why?
| | Sequence Analysis, RNA | 2 | 2024 | 441 | 0.080 |
Why?
| | Placenta | 1 | 2018 | 794 | 0.080 |
Why?
| | Blastocyst | 1 | 2011 | 50 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 4 | 2020 | 2537 | 0.080 |
Why?
| | Models, Genetic | 1 | 2013 | 540 | 0.080 |
Why?
| | Culture Media | 1 | 2011 | 161 | 0.080 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 74 | 0.080 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 76 | 0.080 |
Why?
| | RNA, Long Noncoding | 1 | 2012 | 174 | 0.080 |
Why?
| | Aneuploidy | 1 | 2011 | 88 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2838 | 0.080 |
Why?
| | Pediatric Obesity | 1 | 2017 | 635 | 0.080 |
Why?
| | Liver | 1 | 2018 | 1864 | 0.070 |
Why?
| | Postpartum Period | 1 | 2012 | 377 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 190 | 0.070 |
Why?
| | Sex Factors | 1 | 2015 | 2107 | 0.070 |
Why?
| | Asthma | 1 | 2020 | 1800 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 3 | 2021 | 576 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 882 | 0.060 |
Why?
| | Mice, Nude | 2 | 2021 | 668 | 0.060 |
Why?
| | Rats, Inbred BN | 2 | 2018 | 56 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1331 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2014 | 2791 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2021 | 930 | 0.060 |
Why?
| | Signal Transduction | 1 | 2019 | 5246 | 0.060 |
Why?
| | Rheumatoid Factor | 1 | 2026 | 177 | 0.050 |
Why?
| | Peptides, Cyclic | 1 | 2026 | 276 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2025 | 360 | 0.050 |
Why?
| | Age of Onset | 1 | 2026 | 558 | 0.050 |
Why?
| | Monte Carlo Method | 1 | 2024 | 151 | 0.050 |
Why?
| | Biomarkers | 3 | 2026 | 4340 | 0.050 |
Why?
| | Proteomics | 1 | 2011 | 1203 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 81 | 0.050 |
Why?
| | Body Height | 1 | 2024 | 205 | 0.050 |
Why?
| | Colitis, Ulcerative | 1 | 2024 | 143 | 0.050 |
Why?
| | Up-Regulation | 2 | 2019 | 841 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2025 | 612 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2023 | 137 | 0.040 |
Why?
| | Ascorbic Acid | 1 | 2023 | 183 | 0.040 |
Why?
| | Epitopes | 1 | 2023 | 479 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2020 | 1982 | 0.040 |
Why?
| | Selection Bias | 1 | 2021 | 38 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 54 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 101 | 0.040 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2020 | 4 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 166 | 0.040 |
Why?
| | Apoptosis | 2 | 2021 | 2439 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 91 | 0.040 |
Why?
| | Genomics | 1 | 2026 | 853 | 0.040 |
Why?
| | Probability | 1 | 2021 | 309 | 0.040 |
Why?
| | Bias | 1 | 2021 | 197 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.040 |
Why?
| | Colorado | 2 | 2023 | 4595 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 968 | 0.040 |
Why?
| | Kainic Acid | 1 | 2020 | 33 | 0.040 |
Why?
| | Young Adult | 3 | 2026 | 14330 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 597 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 325 | 0.040 |
Why?
| | Inflammation | 2 | 2024 | 2919 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 194 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 46 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 145 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 588 | 0.040 |
Why?
| | Chimera | 1 | 2019 | 62 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 295 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 496 | 0.030 |
Why?
| | Rats, Transgenic | 1 | 2018 | 20 | 0.030 |
Why?
| | Rats, Inbred SHR | 1 | 2018 | 36 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 166 | 0.030 |
Why?
| | Receptors, AMPA | 1 | 2020 | 148 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2019 | 251 | 0.030 |
Why?
| | Precision Medicine | 1 | 2023 | 462 | 0.030 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 263 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 447 | 0.030 |
Why?
| | Radioligand Assay | 1 | 2017 | 35 | 0.030 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 183 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2019 | 759 | 0.030 |
Why?
| | Adult | 4 | 2026 | 41087 | 0.030 |
Why?
| | Muscle Cells | 1 | 2017 | 41 | 0.030 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 140 | 0.030 |
Why?
| | Electron Transport | 1 | 2017 | 110 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 460 | 0.030 |
Why?
| | Xenopus laevis | 1 | 2017 | 101 | 0.030 |
Why?
| | Carnitine | 1 | 2017 | 91 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2017 | 92 | 0.030 |
Why?
| | Models, Animal | 1 | 2019 | 387 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1181 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 444 | 0.030 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 94 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 114 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 225 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 844 | 0.030 |
Why?
| | Sodium Channel Blockers | 1 | 2016 | 23 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1244 | 0.030 |
Why?
| | Cricetulus | 1 | 2016 | 115 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 335 | 0.030 |
Why?
| | CHO Cells | 1 | 2016 | 167 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2024 | 1210 | 0.030 |
Why?
| | Cricetinae | 1 | 2016 | 296 | 0.030 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2017 | 178 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 195 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 504 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2017 | 6460 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 39 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2360 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1724 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 391 | 0.030 |
Why?
| | Protein Conformation | 1 | 2017 | 916 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 2015 | 202 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2015 | 451 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1309 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1075 | 0.020 |
Why?
| | Amino Acids | 1 | 2017 | 515 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2016 | 750 | 0.020 |
Why?
| | Cell Line | 1 | 2019 | 2814 | 0.020 |
Why?
| | Software | 1 | 2019 | 676 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2921 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1488 | 0.020 |
Why?
| | Basement Membrane | 1 | 2012 | 33 | 0.020 |
Why?
| | Laminin | 1 | 2012 | 72 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 474 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 2092 | 0.020 |
Why?
| | Lipids | 1 | 2017 | 714 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1574 | 0.020 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 175 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2017 | 930 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2012 | 156 | 0.020 |
Why?
| | Embryo Culture Techniques | 1 | 2011 | 11 | 0.020 |
Why?
| | Mothers | 1 | 2017 | 772 | 0.020 |
Why?
| | RNA | 1 | 2017 | 926 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1130 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 506 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1369 | 0.020 |
Why?
| | Mitochondria | 1 | 2017 | 997 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 326 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2021 | 4580 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1827 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2011 | 453 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 846 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 8391 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2599 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 7109 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6073 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2113 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4118 | 0.010 |
Why?
| | Middle Aged | 1 | 2026 | 36619 | 0.010 |
Why?
| | Aged | 1 | 2023 | 26432 | 0.010 |
Why?
|
|
Vanderlinden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|